Pages that link to "Item:Q8395"

← Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395)

What links here

Page:  Namespace:  all (Main) Talk User User talk Wikibase.slis.ua.edu Wikibase.slis.ua.edu talk File File talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Item Item talk Property Property talk Module Module talk   Invert selection

Filters

Show transclusions | Hide links | Hide redirects

The following pages link to Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395):

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

• Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388) ‎ (← links)
• Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) (Q8394) ‎ (← links)
• Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395) ‎ (← links)
• Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396) ‎ (← links)
• Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) (Q8397) ‎ (← links)
• Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398) ‎ (← links)
• Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399) ‎ (← links)
• Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400) ‎ (← links)
• Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) ‎ (← links)
• Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) ‎ (← links)
• Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) ‎ (← links)
• Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404) ‎ (← links)
• Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) ‎ (← links)
• Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406) ‎ (← links)
• Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) (Q8407) ‎ (← links)
• Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8408) ‎ (← links)
• Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409) ‎ (← links)
• Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8410) ‎ (← links)
• Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8411) ‎ (← links)
• Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) (Q8412) ‎ (← links)
• Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413) ‎ (← links)
• Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) ‎ (← links)
• Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415) ‎ (← links)
• Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416) ‎ (← links)
• Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) (Q8417) ‎ (← links)
• Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) (Q8418) ‎ (← links)
• Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) (Q8419) ‎ (← links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)